| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A network meta-analysis of progression free survival and overall survival in first-line treatment of chronic lymphocytic leukemia
|
Ladyzynski, Piotr
|
|
2015
|
41 |
2 |
p. 77-93
17 p.
|
artikel
|
| 2 |
A new era of improving progression-free survival with dual blockade in postmenopausal HR+, HER2− advanced breast cancer
|
Jerusalem, Guy
|
|
2015
|
41 |
2 |
p. 94-104
11 p.
|
artikel
|
| 3 |
A systematic review of factors influencing older adults’ decision to accept or decline cancer treatment
|
Puts, Martine T.E.
|
|
2015
|
41 |
2 |
p. 197-215
19 p.
|
artikel
|
| 4 |
Circulating tumor cell enumeration by the CellSearch system: The clinician’s guide to breast cancer treatment?
|
Beije, Nick
|
|
2015
|
41 |
2 |
p. 144-150
7 p.
|
artikel
|
| 5 |
Crosstalk between bone niche and immune system: Osteoimmunology signaling as a potential target for cancer treatment
|
Criscitiello, Carmen
|
|
2015
|
41 |
2 |
p. 61-68
8 p.
|
artikel
|
| 6 |
Diagnostic and therapeutic ionizing radiation and the risk of a first and second primary breast cancer, with special attention for BRCA1 and BRCA2 mutation carriers: A critical review of the literature
|
Drooger, Jan C.
|
|
2015
|
41 |
2 |
p. 187-196
10 p.
|
artikel
|
| 7 |
Drug radiotherapy combinations: Review of previous failures and reasons for future optimism
|
Higgins, Geoff S.
|
|
2015
|
41 |
2 |
p. 105-113
9 p.
|
artikel
|
| 8 |
Editorial Board
|
|
|
2015
|
41 |
2 |
p. IFC-
1 p.
|
artikel
|
| 9 |
Emerging therapeutic targets in bladder cancer
|
Carneiro, Benedito A.
|
|
2015
|
41 |
2 |
p. 170-178
9 p.
|
artikel
|
| 10 |
Low Grade Serous Ovarian Carcinoma: From the molecular characterization to the best therapeutic strategy
|
Della Pepa, Chiara
|
|
2015
|
41 |
2 |
p. 136-143
8 p.
|
artikel
|
| 11 |
Metallic taste in cancer patients treated with chemotherapy
|
IJpma, I.
|
|
2015
|
41 |
2 |
p. 179-186
8 p.
|
artikel
|
| 12 |
Optimising translational oncology in clinical practice: Strategies to accelerate progress in drug development
|
Stahel, R.
|
|
2015
|
41 |
2 |
p. 129-135
7 p.
|
artikel
|
| 13 |
PD-1 blockade therapy in renal cell carcinoma: Current studies and future promises
|
Massari, F.
|
|
2015
|
41 |
2 |
p. 114-121
8 p.
|
artikel
|
| 14 |
The emerging role of microRNAs in resistance to lung cancer treatments
|
MacDonagh, Lauren
|
|
2015
|
41 |
2 |
p. 160-169
10 p.
|
artikel
|
| 15 |
The role of tumour budding in predicting survival in patients with primary operable colorectal cancer: A systematic review
|
van Wyk, H.C.
|
|
2015
|
41 |
2 |
p. 151-159
9 p.
|
artikel
|
| 16 |
Toll-like receptor 4 signaling: A common biological mechanism of regimen-related toxicities
|
Wardill, Hannah R.
|
|
2015
|
41 |
2 |
p. 122-128
7 p.
|
artikel
|
| 17 |
Triple positive breast cancer: A distinct subtype?
|
Vici, Patrizia
|
|
2015
|
41 |
2 |
p. 69-76
8 p.
|
artikel
|
Tijdschrift beschrijving